Clinical Trial Search block Test
A Randomized, Double-blind, Placebo-controlled Adaptive Phase 2/3 Study with Open-label Extension to Assess the Efficacy, Safety and Tolerability of ASP0367 in Participants with Primary Mitochondrial Myopathy
Astellas_PMM
What is the goal of the study?
To learn more about this study, please email the study team member listed below.
Who can participate in the study?
Everyone